Navigation Links
Carrington's DelSite Presentation at Rodman & Renshaw Conference to be Webcast Live on November 7th
Date:11/5/2007

IRVING, Texas, Nov. 5 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today said the upcoming presentation on DelSite Biotechnologies, Inc., its wholly-owned subsidiary, will be webcast live from the Kennedy I Room at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference at New York City's Palace Hotel on Wednesday, November 7th, at 2:00 pm Eastern Time.

The presentation will cover DelSite's three key platform technologies in the areas of drug delivery and vaccine adjuvants. The Company will also provide an update on the development status of DelSite's lead product candidate. To access the webcast, please log on to the following website: http://www.wsw.com/webcast/rrshq12/carn.pk.

DelSite Biotechnologies specializes in the development of novel liquid and powder formulations for protein/peptide therapeutics and vaccines using its proprietary platform technologies. So far this year, DelSite has signed six technology rights evaluation agreements with commercial partners and institutions that are interested in its delivery technology.

About Carrington

Carrington Laboratories, Inc. is an ISO 9001-certified, research-based, biopharmaceutical and consumer products company currently utilizing naturally-occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care, as well as to manufacture and market the nutraceutical raw material Manapol(R) and cosmetic raw material Hydrapol(TM). Carrington also manufactures and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. Carrington's DelSite Biotechnologies subsidiary is developing its proprietary GelSite(R) technology designed to provide controlled release of peptide and protein-based drugs. Carrington's technology is protected by more than
'/>"/>

SOURCE Carrington Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Carrington Subsidiary DelSite to Present at International Vaccine Conference in Ireland
2. Carrington Subsidiary DelSite to Present at Investor Conference
3. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
4. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
5. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
6. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
7. Haemonetics Webcast Presentation
8. Presentation at Bio Contact Quebec 2007
9. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
10. Accuray to Webcast Senior Management Presentations at Analyst Day Event
11. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 2Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 3Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 4Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 5Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 6Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 7Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 8Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 9Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 10Health News:Fish Really May Be Brain Food 2Health News:DeviceSpace Career Fair Opens Doors for Hundreds of Medical Device and Diagnostics Career Candidates 2Health News:Is Mom or Dad Safe to Live Alone? 2Health News:SpectraScience Acquires Luma Imaging Corporation 2Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 2Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 3Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 4Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 5
Breaking Medicine Technology:NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5Health Insurance Options for Domestic Partnerships 51188 1Health Insurance Options for Domestic Partnerships 51188 2Health Insurance Options for Domestic Partnerships 51188 3Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 1Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 2Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 3Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 4Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 5Statement by Registered Dietitian and American Dietetic Association President Jessie M Pavlinac on Health Reform and Conservation of Natural Resource 51184 1Statement by Registered Dietitian and American Dietetic Association President Jessie M Pavlinac on Health Reform and Conservation of Natural Resource 51184 2